Andrew Scarsbrook
Overview
Explore the profile of Andrew Scarsbrook including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
434
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cairns J, Frood R, Patel C, Scarsbrook A
Semin Nucl Med
. 2025 Mar;
PMID: 40069036
Malignant lymphomas encompass a range of malignancies with incidence rising globally, particularly with age. In younger populations, Hodgkin and Burkitt lymphomas predominate, while older populations more commonly experience subtypes such...
2.
Elhaminia B, Gilbert A, Scarsbrook A, Lilley J, Appelt A, Gooya A
Phys Imaging Radiat Oncol
. 2025 Mar;
33:100710.
PMID: 40046574
Background And Purpose: A comprehensive understanding of radiotherapy toxicity requires analysis of multimodal data. However, it is challenging to develop a model that can analyse both 3D imaging and clinical...
3.
Platt J, Pennycook S, Muthoo C, Westwood A, Frood R, Beggs A, et al.
Eur J Radiol
. 2025 Feb;
185:112000.
PMID: 39978239
In the era of precision oncology, systemic therapies for colon cancer are becoming increasingly biomarker-led, with implications for patients in the neoadjuvant, adjuvant and metastatic settings. As the landscape for...
4.
Gravell R, Frood R, Littlejohns A, Casanova N, Goody R, Podesta C, et al.
Curr Oncol
. 2024 Oct;
31(10):6384-6394.
PMID: 39451778
Background: The study purpose was to develop a machine learning (ML)-based predictive model for event-free survival (EFS) in patients with hepatocellular carcinoma (HCC) undergoing stereotactic ablative radiotherapy (SABR). Methods: Patients...
5.
Winder C, Clark M, Frood R, Smith L, Bulpitt A, Cook G, et al.
Eur J Radiol
. 2024 Oct;
181:111764.
PMID: 39368243
Purpose: To review methodological approaches for automated segmentation of subcutaneous adipose tissue, visceral adipose tissue, and skeletal muscle from abdominal cross-sectional imaging for body composition analysis. Method: Four databases were...
6.
Stogiannos N, Gillan C, Precht H, Sa Dos Reis C, Kumar A, ORegan T, et al.
J Med Imaging Radiat Sci
. 2024 Jul;
55(4):101717.
PMID: 39067309
No abstract available.
7.
Singh Dhesi S, Frood R, Swift S, Cooper R, Muzumdar S, Jamal M, et al.
Cancers (Basel)
. 2024 Feb;
16(3).
PMID: 38339229
Purpose: To evaluate the utility and comparative effectiveness of three five-point qualitative scoring systems for assessing response on PET-CT and MRI imaging individually and in combination, following curative-intent chemoradiotherapy (CRT)...
8.
ODowd E, Berovic M, Callister M, Chalitsios C, Chopra D, Das I, et al.
BMJ Open
. 2024 Jan;
14(1):e077747.
PMID: 38176863
Introduction: In a small percentage of patients, pulmonary nodules found on CT scans are early lung cancers. Lung cancer detected at an early stage has a much better prognosis. The...
9.
Frood R, Mercer J, Brown P, Appelt A, Mistry H, Kochhar R, et al.
Eur Radiol
. 2023 Nov;
34(5):3194-3204.
PMID: 37924344
Objectives: The incidence of anal squamous cell carcinoma (ASCC) is increasing worldwide, with a significant proportion of patients treated with curative intent having recurrence. The ability to accurately predict progression-free...
10.
Zhong J, Kobus M, Maitre P, Datta A, Eccles C, Dubec M, et al.
Radiographics
. 2023 Oct;
43(11):e230052.
PMID: 37796729
Radiation therapy (RT) is a core pillar of oncologic treatment, and half of all patients with cancer receive this therapy as a curative or palliative treatment. The recent integration of...